Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

5.96USD
23 May 2018
Change (% chg)

$0.04 (+0.68%)
Prev Close
$5.92
Open
$5.97
Day's High
$5.97
Day's Low
$5.93
Volume
534
Avg. Vol
56,922
52-wk High
$15.78
52-wk Low
$4.42

Select another date:

Tue, Jan 16 2018

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

Select another date: